Scientific Sessions 2025  /  Biological and Pragmatic Interventions in Heart Failure: From Present to Future  /  Discussant: The MAPLE-HCM Trial
Logo

American Heart Association

  53
  0

Final ID:

Discussant: The MAPLE-HCM Trial

  • Day, Sharlene  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
    • Author Disclosures:
    Sharlene Day: DO have relevant financial relationships ; Consultant:Lexicon Pharmaceuticals:Active (exists now) ; Research Funding (PI or named investigator):BMS:Active (exists now) ; Consultant:Solid Biosciences:Active (exists now) ; Advisor:Cytokinetics:Active (exists now) ; Research Funding (PI or named investigator):Lexicon Pharmaceuticals:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Biological and Pragmatic Interventions in Heart Failure: From Present to Future

Sunday, 11/09/2025 , 08:00AM - 09:15AM

Featured Science

More abstracts on this topic:
Discussant: ANSWER-HF

Pfeffer Marc, Solomon Scott, Lopes Renato

First-in-Human Gene Therapy Trial for Patients with Heart Failure with preserved Ejection Fraction (HFpEF)

Fudim Marat, Rudy Jeffrey, Guerrero Janet, Chan Camie, Patel Manesh, Bavry Anthony, Li Ronald, Sarma Satyam, Macnamara James, Levine Benjamin, Hajjar Roger, Ascheim Deborah, Grodin Justin, Kittipibul Veraprapas, Doukellis Katheryn, Dhimitri Andy, Fitzhugh Robert, Karmat Niharika, Costa Kevin

More abstracts from these authors:
Hypertrophic Cardiomyopathy

Day Sharlene

Molecular Regulation of Hypertrophic Signaling Pathways

Day Sharlene

You have to be authorized to contact abstract author. Please, Login
Not Available